Page last updated: 2024-08-22

tetrapentylammonium and Neuralgia

tetrapentylammonium has been researched along with Neuralgia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, Z; Koivisto, A; Pertovaara, A; Sagalajev, B; Wei, H	1

Other Studies

1 other study(ies) available for tetrapentylammonium and Neuralgia

Article	Year
Amygdaloid administration of tetrapentylammonium attenuates development of pain and anxiety-like behavior following peripheral nerve injury. Pharmacological reports : PR, 2019, Volume: 71, Issue:1 Topics: Amygdala; Analgesics; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Disease Models, Animal; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Locomotion; Male; Microglia; Microinjections; Minocycline; Neuralgia; Pain Perception; Pain Threshold; Peripheral Nerve Injuries; Potassium Channels, Tandem Pore Domain; Quaternary Ammonium Compounds; Rats, Wistar; Receptors, N-Methyl-D-Aspartate	2019

Article

Year

Amygdaloid administration of tetrapentylammonium attenuates development of pain and anxiety-like behavior following peripheral nerve injury.

Pharmacological reports : PR, 2019, Volume: 71, Issue:1

Topics: Amygdala; Analgesics; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Disease Models, Animal; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Locomotion; Male; Microglia; Microinjections; Minocycline; Neuralgia; Pain Perception; Pain Threshold; Peripheral Nerve Injuries; Potassium Channels, Tandem Pore Domain; Quaternary Ammonium Compounds; Rats, Wistar; Receptors, N-Methyl-D-Aspartate

2019